Design, synthesis, and biological evaluation of a series of benzo[de][1,7]naphthyridin-7(8H)-ones bearing a functionalized longer chain appendage as novel PARP1 inhibitors
about
Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent c-Met/ALK Multikinase Inhibitory Activities.Therapeutic Potential of Spirooxindoles as Antiviral AgentsNovel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution.Tankyrases: structure, function and therapeutic implications in cancer.Discovery of potent 2,4-difluoro-linker poly(ADP-ribose) polymerase 1 inhibitors with enhanced water solubility and in vivo anticancer efficacy.PARP inhibitors as antitumor agents: a patent update (2013-2015).Structural basis for the inhibition of poly(ADP-ribose) polymerases 1 and 2 by BMN 673, a potent inhibitor derived from dihydropyridophthalazinone.Enantioselective Rh-Catalyzed Carboacylation of C═N Bonds via C-C Activation of Benzocyclobutenones.Contrasting sirtuin and poly(ADP-ribose)polymerase activities of selected 2,4,6-trisubstituted benzimidazoles.Acquired resistance of phosphatase and tensin homolog-deficient cells to poly(ADP-ribose) polymerase inhibitor and Ara-C mediated by 53BP1 loss and SAMHD1 overexpression.Active site fingerprinting and pharmacophore screening strategies for the identification of dual inhibitors of protein kinase C [Formula: see text] and poly (ADP-ribose) polymerase-1 (PARP-1).Identification of novel 2-(benzo[d]isoxazol-3-yl)-2-oxo-N-phenylacetohydrazonoyl cyanide analoguesas potent EPAC antagonists.Combining 53BP1 with BRCA1 as a biomarker to predict the sensitivity of poly(ADP-ribose) polymerase (PARP) inhibitors.
P2860
Q33636098-0DE43B99-8025-4C72-8D3B-60880594CA21Q33637160-EBE4F76B-3866-4FD8-BD4A-F30DD79E5090Q37706153-F431E31C-E8BD-4C30-9F36-2E8B96AF4332Q38224266-B653B10E-872E-4AF9-AB92-08AAAFF36C9BQ38644956-ECC66BEB-08AA-43CC-A048-099052FFD604Q38795712-3B72484C-6890-46CB-A3AF-F0485AF4FBB4Q40220408-AFAB1024-12D6-4DB2-9AFE-E956E1EC902BQ42002908-391C1C43-F6C2-4C91-9DCF-3C7E9B829035Q48108671-AA1D758A-1570-4FA8-BE03-EDD42DE8771BQ48352256-1D220EE4-4C1A-480F-8DAD-548766F5086DQ50639847-B211CE8C-6319-48D5-BA60-E5FE02BBA703Q51063407-9D454D3F-D541-4F28-B3CF-E5A7DC921ACDQ52776578-B992291A-8483-4B6C-9C95-D8FBEA520DA4
P2860
Design, synthesis, and biological evaluation of a series of benzo[de][1,7]naphthyridin-7(8H)-ones bearing a functionalized longer chain appendage as novel PARP1 inhibitors
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Design, synthesis, and biologi ...... dage as novel PARP1 inhibitors
@ast
Design, synthesis, and biologi ...... dage as novel PARP1 inhibitors
@en
Design, synthesis, and biologi ...... dage as novel PARP1 inhibitors
@nl
type
label
Design, synthesis, and biologi ...... dage as novel PARP1 inhibitors
@ast
Design, synthesis, and biologi ...... dage as novel PARP1 inhibitors
@en
Design, synthesis, and biologi ...... dage as novel PARP1 inhibitors
@nl
prefLabel
Design, synthesis, and biologi ...... dage as novel PARP1 inhibitors
@ast
Design, synthesis, and biologi ...... dage as novel PARP1 inhibitors
@en
Design, synthesis, and biologi ...... dage as novel PARP1 inhibitors
@nl
P2093
P356
P1476
Design, synthesis, and biologi ...... dage as novel PARP1 inhibitors
@en
P2093
Chuan-Huizi Chen
Jin-Xue He
Qiufeng Liu
Shan-Shan Song
Tiantian Chen
Xia-Juan Huan
P304
P356
10.1021/JM301825T
P407
P577
2013-04-11T00:00:00Z